Eloha Vol 1

• Description

Eloha Vol 1 is a cross-linked hyaluronic acid- (HA)-based filler with a mixed mono- and biphasic structure. The ratio of mono- and biphasic HA in Eloha Vol 1 is 1 to 1. Such a combination results in longer effect duration, greater filler fluidity and plasticity, as well as the lack of the risk of filler migration. In addition, due to the exceptional hybrid-type structure of Eloha fillers, they are more evenly distributed in the dermal layers while occupying as much space as possible, which provides a natural-looking effect.

Strengths of Eloha:

• the first HA filler with a hybrid biphasic-monophasic structure
• multilayer HA structure delays filler degradation and ensures long aesthetic effect duration
• natural-looking effect due to the hybrid HA gel structure
• the Eloha series contains three products varying in the ratio of monophasic HA to biphasic HA particles depending on the scope of use
• no filler migration to adjacent tissues
• smooth and ease gel injection reduces the risk of post-injection swelling and bruises

Eloha Vol 1 is used for biorevitalization, correction of superficial and moderately pronounced facial wrinkles, and lip augmentation. The filler is injected in the superficial and mid dermis.

Scope of Eloha Vol 1:

• deep skin hydration and rejuvenation
• periorbital area wrinkles, filling of lacrimal groove
• correction of glabellar, nasolabial, and neck lines
• lip line correction and mild augmentation

The aesthetic effect lasts from 6 to 9 months.

Product composition: HA 20 mg/ml, Lidocaine 0.3%

Eloha Vol 1

1 syringe × 1.0 ml, 2 needles per pack

Needle size: 27G, 30G

Manufacturer: Daewoong Co., Ltd., South Korea

The product has contraindications. We are not responsible for any negative effects that you may encounter after administering products by yourself. Consulting a doctor or medical professional is recommended prior to any procedure.